[Chloroquine--therapy of atopic dermatitis].
In 1984 and 1985, 62 patients suffering from atopic dermatitis were systemically treated with chloroquine for 3 to 6 months. In 46 of the patients, the therapy resulted in significant improvement, so that all systemic or topical treatment with glucocorticoids could be discontinued. 8 patients revealed moderate improvement, which did not allow the discontinuation of topical glucocorticoids. 6 patients showed adverse reactions, which forced us to stop therapy with chloroquine. 2 patients broke off therapy because of side effects.
Döring
H F
HF
Müllejans-Kreppel
U
U
D000293:Adolescent; D000328:Adult; D000368:Aged; D002738:Chloroquine / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008875:Middle Aged
D002738:Chloroquine
Chloroquin--Therapie der atopischen Dermatitis.